Document is current
Any future updates will be listed below
-
Authors
Warmerdam, Mats I. https://orcid.org/0000-0002-4546-5966
Creemers, Davy M. J.
Kusters, Miranda
Peeters, Koen C. M. J.
Holman, Fabian A.
Mieog, J. Sven D.
Cailler, Francoise
Burger, Pim J. W. A.
Burggraaf, Jacobus
Rutten, Harm J. T.
Verhoef, Cornelis
Vahrmeijer, Alexander L.
Hilling, Denise E.
- License Information
-
More Information
Article History
Received: 5 October 2024
Revised: 19 March 2025
Accepted: 21 May 2025
First Online: 5 June 2025
Conflict of interest
: F. Cailler is employed by SurgiMab, which owns the SGM-101 conjugate. F. Cailler is part of the SurgiMab founders and is stockholder. All other authors declare no competing interests.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.
